This study evaluates the effectiveness of the various treatment options as well as health behaviors and long term outcomes for patients with localized prostate cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02564120.
Locations matching your search criteria
United States
North Carolina
Chapel Hill
UNC Lineberger Comprehensive Cancer CenterStatus: Approved
Contact: Matthew Edward Nielsen
Phone: 919-966-8217
PRIMARY OBJECTIVES:
I. To directly compare the disease characteristics at diagnosis, quality of life (QOL), recurrence and survival in prostate cancer patients, stratified by treatment type, race/ethnicity, urban/rural residence, and other sociodemographic characteristics.
II. Study healthcare utilization in prostate cancer patients among different treatment options.
III. To assess post-treatment survivorship care (including primary/preventive care and cancer monitoring) in prostate cancer survivors.
OUTLINE: This is an observational study.
Participants complete surveys and have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUNC Lineberger Comprehensive Cancer Center
Principal InvestigatorMatthew Edward Nielsen
